Product Information
CELESTONE SOLUSPAN 30 MG/5 ML is a brand product labeled by Organon LLC, priced at $8.8680 per ML under NDC 78206011801. Its NADAC has been published 221 times since Sep 15, 2021.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
3; 3 mg/mL; mg/mL
Manufacturer
Organon LLCNDC
78206011801
Classification
Brand
Dosage Form
INJECTION, SUSPENSION
Route
INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; SOFT TISSUE
Effective Date
9/23/2026
Active Ingredients
BETAMETHASONE ACETATE; BETAMETHASONE SODIUM PHOSPHATEApproval Type
New Drug (NDA)
FDA Application
NDA014602FDA Approved
Before 1982
TE Code
AB
On Market Since
6/1/2021
Pharmacological Classes
Price Statistics
The NADAC for CELESTONE SOLUSPAN 30 MG/5 ML has been published 221 times since Sep 15, 2021, and over the history we have for it it has risen 23.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.8680 per ML |
|---|---|
| All-time high | $8.8680 (Sep 30, 2026) |
| All-time low | $7.1900 (Sep 15, 2021) |
| 52-week high | $8.8680 |
| 52-week low | $8.3580 |
| Median price | $7.9747 |
| Average price | $8.1278 |
| Largest weekly change | +6.0% (Jan 18, 2023) |
| Weeks tracked | 221 |
| Tracking since | Sep 15, 2021 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Betamethasone Acetate and Betamethasone Sodium Phosphate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Organon LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Betamethasone Acetate and Betamethasone Sodium Phosphate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CELESTONE SOLUSPAN 30 MG/5 ML?
The current National Average Drug Acquisition Cost (NADAC) for CELESTONE SOLUSPAN 30 MG/5 ML, manufactured by Organon LLC, is $8.8680 per ML (NDC 78206011801), effective Sep 30, 2026.
How has the price of CELESTONE SOLUSPAN 30 MG/5 ML changed over time?
Over the history we have for it, the NADAC for CELESTONE SOLUSPAN 30 MG/5 ML has risen 23.3%. It has been tracked across 221 weekly CMS publications since Sep 15, 2021.
What are the highest and lowest recorded NADAC prices for CELESTONE SOLUSPAN 30 MG/5 ML?
Since Sep 15, 2021, the NADAC for CELESTONE SOLUSPAN 30 MG/5 ML has ranged from a low of $7.1900 (Sep 15, 2021) to a high of $8.8680 (Sep 30, 2026), with a median of $7.9747 per ML.
Are there cheaper alternatives to CELESTONE SOLUSPAN 30 MG/5 ML?
No other NADAC-published product currently shares the active ingredient and strength of CELESTONE SOLUSPAN 30 MG/5 ML in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CELESTONE SOLUSPAN 30 MG/5 ML?
CELESTONE SOLUSPAN 30 MG/5 ML (NDC 78206011801) is labeled by Organon LLC, and CMS classifies it as a brand product.